Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health, talks about how the responsibility for saving costs does not just fall on one department or person, but is collaborative and requires strategy.
Reducing costs falls on multiple health care departments, and the help of data, analytics, and specialty pharmacy strategies can ensure that cost reduction is successful, says Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health.
Transcript
What strategies are health systems employing to combat the increasing costs of specialty drugs within their specialty pharmacy programs?
It's really about employing a collaborative approach. It's not just a pharmacy problem of controlling costs. It's also patient navigators, the pharmacy department, the billing department, ensuring that things are getting built properly before it's administered to a patient, where it ends up being a cost to the hospital.
How are health systems leveraging data and analytics to identify cost-saving opportunities and make informed decisions regarding specialty drug pricing and procurement?
This iswhere the importance of a specialty GPO [group purchasing organizations] comes into play. Specialty GPOs can help with these data analytics and ensure that the hospitals are buying the best possible drug at the least possible cost.
Are there any best practices or success stories of health system specialty pharmacy strategies that have effectively tackled the challenge of escalating specialty drug costs?
There's many hospitals that have employed strategies that, really from a retail perspective, of getting specialty drugs into the community. So, from hospital into community of ordering these drugs, and now they become a revenue to the hospital versus just simply a cost. That's where a specialty pharmacy strategy really makes sense, and where hospitals are finding success. It also helps with the patient end to end approach where the hospital is able to work with patients on the outside when they become outpatients. It improves compliance, It improves outcomes, and it controls overall health care costs.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
2 Commerce Drive
Cranbury, NJ 08512